JPH0522688B2 - - Google Patents
Info
- Publication number
- JPH0522688B2 JPH0522688B2 JP59252288A JP25228884A JPH0522688B2 JP H0522688 B2 JPH0522688 B2 JP H0522688B2 JP 59252288 A JP59252288 A JP 59252288A JP 25228884 A JP25228884 A JP 25228884A JP H0522688 B2 JPH0522688 B2 JP H0522688B2
- Authority
- JP
- Japan
- Prior art keywords
- freeze
- compound
- stabilizer
- hours
- alkali metal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000003381 stabilizer Substances 0.000 claims description 7
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- -1 alkali metal salt Chemical class 0.000 claims description 3
- 229910001508 alkali metal halide Inorganic materials 0.000 claims description 2
- 150000008045 alkali metal halides Chemical class 0.000 claims description 2
- 125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000004108 freeze drying Methods 0.000 description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 150000001340 alkali metals Chemical group 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000012931 lyophilized formulation Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59252288A JPS61130223A (ja) | 1984-11-28 | 1984-11-28 | 抗菌性凍結乾燥製剤 |
FR8517383A FR2573654B1 (fr) | 1984-11-28 | 1985-11-25 | Preparations antibacteriennes lyophilisees |
GB08529182A GB2167302B (en) | 1984-11-28 | 1985-11-27 | Stable lyophilized antibacterial-preparations |
DE19853541952 DE3541952A1 (de) | 1984-11-28 | 1985-11-27 | Lyophilisiertes, antibakterielles praeparat |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59252288A JPS61130223A (ja) | 1984-11-28 | 1984-11-28 | 抗菌性凍結乾燥製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61130223A JPS61130223A (ja) | 1986-06-18 |
JPH0522688B2 true JPH0522688B2 (pt) | 1993-03-30 |
Family
ID=17235167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59252288A Granted JPS61130223A (ja) | 1984-11-28 | 1984-11-28 | 抗菌性凍結乾燥製剤 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS61130223A (pt) |
DE (1) | DE3541952A1 (pt) |
FR (1) | FR2573654B1 (pt) |
GB (1) | GB2167302B (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4808617A (en) * | 1985-12-18 | 1989-02-28 | Bristol-Myers Company | Lyophilized or precipitated cephalosporin zwitterion and salt combination |
JP3072479B2 (ja) * | 1997-06-10 | 2000-07-31 | 丸石自転車株式会社 | 車椅子 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52143285A (en) * | 1976-05-26 | 1977-11-29 | Kikkoman Corp | Stabilization of cholesterol-oxydase |
JPS5962596A (ja) * | 1982-09-30 | 1984-04-10 | Shionogi & Co Ltd | ビニルチオ化オキサセフアロスポリン誘導体 |
JPS59139323A (ja) * | 1983-01-28 | 1984-08-10 | Green Cross Corp:The | ウロキナ−ゼ乾燥製剤 |
JPS59196899A (ja) * | 1983-04-20 | 1984-11-08 | Kyowa Hakko Kogyo Co Ltd | インタ−フエロンの安定化方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK163000C (da) * | 1982-09-30 | 1992-06-01 | Shionogi & Co | Analogifremgangsmaade til fremstilling af vinylthioacetamido-1-dethia-1-oxa-cephalosporinderivater |
JPS6045514A (ja) * | 1983-08-22 | 1985-03-12 | Shionogi & Co Ltd | 安定な抗菌性凍結乾燥製剤 |
-
1984
- 1984-11-28 JP JP59252288A patent/JPS61130223A/ja active Granted
-
1985
- 1985-11-25 FR FR8517383A patent/FR2573654B1/fr not_active Expired
- 1985-11-27 GB GB08529182A patent/GB2167302B/en not_active Expired
- 1985-11-27 DE DE19853541952 patent/DE3541952A1/de not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52143285A (en) * | 1976-05-26 | 1977-11-29 | Kikkoman Corp | Stabilization of cholesterol-oxydase |
JPS5962596A (ja) * | 1982-09-30 | 1984-04-10 | Shionogi & Co Ltd | ビニルチオ化オキサセフアロスポリン誘導体 |
JPS59139323A (ja) * | 1983-01-28 | 1984-08-10 | Green Cross Corp:The | ウロキナ−ゼ乾燥製剤 |
JPS59196899A (ja) * | 1983-04-20 | 1984-11-08 | Kyowa Hakko Kogyo Co Ltd | インタ−フエロンの安定化方法 |
Also Published As
Publication number | Publication date |
---|---|
JPS61130223A (ja) | 1986-06-18 |
FR2573654A1 (fr) | 1986-05-30 |
DE3541952A1 (de) | 1986-05-28 |
GB2167302B (en) | 1988-08-10 |
FR2573654B1 (fr) | 1987-05-07 |
GB2167302A (en) | 1986-05-29 |
GB8529182D0 (en) | 1986-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4329453A (en) | Cephalosporin antibiotic | |
JPH0370688B2 (pt) | ||
AU758857B2 (en) | Pharmaceutical compositions for freeze drying | |
JPS6364405B2 (pt) | ||
HU199686B (en) | Process for producing combination of liophylized or precipitated diion forme and salt of cephalosporin | |
JP2958567B2 (ja) | 非経口用凍結乾燥bmy―28142ジ塩酸塩 | |
JPH0522688B2 (pt) | ||
KR930001830B1 (ko) | 항균성 동결건조 제제 | |
US4222939A (en) | Process for preparing solid sodium amoxycillin | |
JPS5936616A (ja) | セフアロスポリン誘導体の安定な医薬組成物 | |
JP2004269401A (ja) | 凍結乾燥製剤 |